Skip to Main Content

Author Details

Robert B Robey
Geisel School of Medicine at Dartmouth and US Department of Veterans Affairs
1987
51
24
PMIDPaper TitleJournal TitlePublished Year
28710094Perspectives from the Kidney Health Initiative on Advancing Technologies to Facilitate Remote Monitoring of Patient Self-Care in RRT.Clin J Am Soc Nephrol2017
28224939Targeting Access to Kidney Care Via Telehealth: The VA Experience.Adv Chronic Kidney Dis2017
27742616Chronic Kidney Disease Progression and Cardiovascular Outcomes Following Cardiac Catheterization-A Population-Controlled Study.J Am Heart Assoc2016
26057293Varenicline for smoking reduction prior to cessation.JAMA2015
26590477Designing a broad-spectrum integrative approach for cancer prevention and treatment.Semin Cancer Biol2015
26106142Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead.Carcinogenesis2015
26106140Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?Carcinogenesis2015
24399567Changing the terminology of cancer.JAMA2014
25079017Cyclical dehydration-induced renal injury and Mesoamerican nephropathy: as sweet by any other name?Kidney Int2014
23576577"Does sunscreen promote hypertension?" and other questions. Novel interactions between vitamin D and the renin-angiotensin axis. Focus on "The world pandemic of vitamin D deficiency could possibly be explained by cellular inflammatory response activity induced by the renin-angiotensin system".Am J Physiol Cell Physiol2013
23911236Hexokinase 2 is required for tumor initiation and maintenance and its systemic deletion is therapeutic in mouse models of cancer.Cancer Cell2013
23747316Peptides modeled on the RGG domain of AUF1/hnRNP-D regulate 3' UTR-dependent gene expression.Int Immunopharmacol2013
22379108AUF1/hnRNP D represses expression of VEGF in macrophages.Mol Biol Cell2012
22910952Effects of antiplatelet therapy on mortality and cardiovascular and bleeding outcomes in persons with chronic kidney disease.Ann Intern Med2012
22511680Potassium levels after acute myocardial infarction.JAMA2012
21566638Hexokinase: a novel sugar kinase coupled to renal epithelial cell survival.Kidney Int2011
19153420Does furosemide have a role in the management of hypercalcemia?Ann Intern Med2009
19620286mTORC1 hyperactivity inhibits serum deprivation-induced apoptosis via increased hexokinase II and GLUT1 expression, sustained Mcl-1 expression, and glycogen synthase kinase 3beta inhibition.Mol Cell Biol2009
19406679Reduced susceptibility to azoxymethane-induced aberrant crypt foci formation and colon cancer in growth hormone deficient rats.Growth Horm IGF Res2009
19130886Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis.Semin Cancer Biol2009
17242304Functional polymorphism of the Anpep gene increases promoter activity in the Dahl salt-resistant rat.Hypertension2007
16892082Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt.Oncogene2006
15846094Mitochondrial hexokinases: guardians of the mitochondria.Cell Cycle2005
15070811Proinflammatory interleukin-1 cytokines increase mesangial cell hexokinase activity and hexokinase II isoform abundance.Am J Physiol Cell Physiol2004
15574336Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak.Mol Cell2004
15291758Insulin-mediated activation of activator protein-1 through the mitogen-activated protein kinase pathway stimulates collagenase-1 gene transcription in the MES 13 mesangial cell line.J Mol Endocrinol2004
14701745Akt inhibits apoptosis downstream of BID cleavage via a glucose-dependent mechanism involving mitochondrial hexokinases.Mol Cell Biol2004
15048134Vascular factors altered in glucose-treated mesangial cells and diabetic glomeruli. Changes in vascular factors impair endothelial cell growth and matrix.Lab Invest2004
12533781The role of phosphatidylinositol 3-kinase (PI3K) in CO2 stimulation of the Na+/HCO3- cotransporter (NBC).J Membr Biol2003
12949233Caveat experimentor: reporting expression profiling data involving multiple, functionally redundant isoforms.J Leukoc Biol2003
11751868Increased hexokinase activity, of either ectopic or endogenous origin, protects renal epithelial cells against acute oxidant-induced cell death.J Biol Chem2002
12217857A central role for Pyk2-Src interaction in coupling diverse stimuli to increased epithelial NBC activity.Am J Physiol Renal Physiol2002
12029370Angiotensin II stimulation of renal epithelial cell Na/HCO3 cotransport activity: a central role for Src family kinase/classic MAPK pathway coupling.J Membr Biol2002
12110510LPA is a novel lipid regulator of mesangial cell hexokinase activity and HKII isoform expression.Am J Physiol Renal Physiol2002
11782486Regulation of mesangial cell hexokinase activity and expression by heparin-binding epidermal growth factor-like growth factor: epidermal growth factors and phorbol esters increase glucose metabolism via a common mechanism involving classic mitogen-activated protein kinase pathway activation and induction of hexokinase II expression.J Biol Chem2002
11390360Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase.Genes Dev2001
11292627SFKs, Ras, and the classic MAPK pathway couple muscarinic receptor activation to increased Na-HCO(3) cotransport activity in renal epithelial cells.Am J Physiol Renal Physiol2001
10844601Thrombin is a novel regulator of hexokinase activity in mesangial cells.Kidney Int2000
10516283Regulation of the renal Na-HCO(3) cotransporter. XI. Signal transduction underlying CO(2) stimulation.Am J Physiol1999
10411549Basolateral Na(+)/HCO(3)(-) cotransport activity is regulated by the dissociable Na(+)/H(+) exchanger regulatory factor.J Clin Invest1999
10564237Regulation of mesangial cell hexokinase activity by PKC and the classic MAPK pathway.Am J Physiol1999
9665694pH-dependent fluorescence of a heterologously expressed Aequorea green fluorescent protein mutant: in situ spectral characteristics and applicability to intracellular pH estimation.Biochemistry1998
8663315Analysis of the signaling pathway involved in the regulation of hexokinase II gene transcription by insulin.J Biol Chem1996
8770402Transient gene transfer into myotubes following differentiation in culture.Biotechniques1996
8617267Induction of the glucokinase gene by insulin in cultured neonatal rat hepatocytes. Relationship with DNase-I hypersensitive sites and functional analysis of a putative insulin-response element.Eur J Biochem1996
8663388Identification and characterization of basal and cyclic AMP response elements in the promoter of the rat hexokinase II gene.J Biol Chem1996
1370453Cloning of a Na(+)- and Cl(-)-dependent betaine transporter that is regulated by hypertonicity.J Biol Chem1992
2037590Induction of glycinebetaine uptake into Xenopus oocytes by injection of poly(A)+ RNA from renal cells exposed to high extracellular NaCl.J Biol Chem1991
1996676Renal Na-myo-inositol cotransporter mRNA expression in Xenopus oocytes: regulation by hypertonicity.Am J Physiol1991
2220741Toxoplasmic chorioretinitis and hepatic granulomas.Am J Gastroenterol1990
  • 1 - 50 of 51

Recommended Authors

Interfaculty Institute for Cell Biology.
Career Start Year 2003
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 2003
Number of shared co-authors 0
University of Florida
Career Start Year 2001
Number of shared co-authors 1
Cumming School of Medicine, University of Calgary, 0 Hospital Drive NW
Career Start Year 2000
Number of shared co-authors 0
Harvard Medical School
Career Start Year 2000
Number of shared co-authors 0
David Geffen School of Medicine, University of California at Los Angeles
Career Start Year 1994
Number of shared co-authors 0
University of Michigan ann arbor
Career Start Year 1994
Number of shared co-authors 0
Lady Hardinge Medical College and Associated SSK and KSC Hospitals
Career Start Year 1992
Number of shared co-authors 0
Hasso Plattner Institute for Digital Health at Mount Sinai
Career Start Year 1992
Number of shared co-authors 1
Institute for Precision Cardiovascular Medicine
Career Start Year 1992
Number of shared co-authors 0
University of Otago
Career Start Year 1991
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 1986
Number of shared co-authors 0
University of California San Francisco
Career Start Year 1986
Number of shared co-authors 0
University Health Network, University of Toronto
Career Start Year 1986
Number of shared co-authors 0
Eastern Virginia Medical School
Career Start Year 1985
Number of shared co-authors 0
Institute of Neurophysiology, University of Cologne
Career Start Year 1985
Number of shared co-authors 0
Odense University Hospital
Career Start Year 1985
Number of shared co-authors 0
Oregon Health and Science University
Career Start Year 1984
Number of shared co-authors 1
Vanderbilt University Medical Center
Career Start Year 1984
Number of shared co-authors 1
University of Virginia School of Medicine
Career Start Year 1982
Number of shared co-authors 0
Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital
Career Start Year 1982
Number of shared co-authors 0
Duke Molecular Physiology Institute
Career Start Year 1981
Number of shared co-authors 2
Feinberg School of Medicine, Northwestern University
Career Start Year 1981
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1978
Number of shared co-authors 1
Yale University School of Medicine
Career Start Year 1978
Number of shared co-authors 1
Brigham & Women's Hospital
Career Start Year 1975
Number of shared co-authors 2
National Academy of Medicine.
Career Start Year 1974
Number of shared co-authors 1
Oregon Health and Science University
Career Start Year 1973
Number of shared co-authors 0
Research Center of the CHU de Quebec-Universite Laval, Universite Laval
Career Start Year 1971
Number of shared co-authors 0
Montreal University Hospital Research Center
Career Start Year 1967
Number of shared co-authors 0

Collaborators

Dasman Diabetes Institute
Co-authored papers 2
Harvard Medical School
Co-authored papers 2
Co-authored papers 2
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 2
Co-authored papers 2
American College of Medical Informatics, Department of Veteran Affairs, Harvard University T H Chan School of Public Health, Massachusetts Institute of Technology, The American Society for Clinical Investigation, University of Kentucky, Vanderbilt University Medical Center, Vanderbilt University Medical School
Co-authored papers 1
University of Virginia Health
Co-authored papers 1
Co-authored papers 1
Institute for Health Research, Kaiser Permanente
Co-authored papers 1
Stanford University
Co-authored papers 1
Co-authored papers 1
Kresge Hearing Research Institute, University of Michigan ann arbor
Co-authored papers 1
Duke University Nicholas School of the Environment.
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Elucidata Corporation
Co-authored papers 1
Geisel School of Medicine at Dartmouth
Co-authored papers 1
Oncode Institute
Co-authored papers 1
Rocky Mountain Regional VA Medical Center
Co-authored papers 1
Duke Molecular Physiology Institute, Duke University School of Medicine
Co-authored papers 1
Co-authored papers 1
Duke University
Co-authored papers 1
University of Vermont Larner College of Medicine
Co-authored papers 1
Duke University
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Inc. Research Triangle Park
Co-authored papers 1
Washington University School of Medicine
Co-authored papers 1
Co-authored papers 1
University of Maryland School of Medicine
Co-authored papers 1